SQSTM1 and nasopharyngeal carcinoma: Western blot showed that both inhibitors reversed the downregulation of SQSTM1 in the ANXA1 KD NPC cells, but only had slight effect on SQSTM1 levels in the scramble shRNA control NPC cells (Fig. 1d).